Skip to main content
letter
. 2018 Mar 30;184(4):676–679. doi: 10.1111/bjh.15155

Figure 1.

Figure 1

Prevalence and amino acid specificity of type 3 histone mutations in different cancer types. Columns indicate cancer types and rows show key histone type 3 regulatory residues. Tiles are coloured according to amino acid substitution. The percentage of each tumour type affected by the given class of histone mutation is indicated within the tiles and the overall prevalence of histone mutations is summarised at the bottom of each column. NBS HGG, non‐brain stem high grade glioma; DIPG, diffuse intrinsic pontine glioma; ASTR, astrocytoma; AML, acute myeloid leukaemia; T‐ALL, T cell acute lymphoblastic leukaemia; OS, osteosarcoma; ADM, adamantinoma; GCTB, giant cell tumour of bone; CCC, clear cell chondrosarcoma; CB, chondroblastoma; CS, chondrosarcoma.